COPILOT continues to be led by its two Co-founders, CEO Nuaman Tyyeb, and President Moby Kazmi, MD.
The COPILOT leadership team has decades of pharmaceutical industry, reimbursement HUB operations, specialty
pharmacy and payer experience, leveraged to provide our clients with the strategic guidance needed to create
industry leading reimbursement programs.
Headquartered in Orlando, FL and with locations in Long Island, NY and Scottsdale, AZ, COPILOT has the
infrastructure to support both large volume products and small population rare disorder treatments.
The COPILOT team incorporates extensive experience in transitioning established HUBs and in the creation of
new programs in conjunction with product launches to achieve a high level of client care.
COPILOT operations are structured to work within the framework of fully integrated pharmaceutical organizations
and nimble enough to align with emerging life-science organizations.